Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;64(4):e1900797.
doi: 10.1002/mnfr.201900797. Epub 2019 Nov 7.

The Potential of Probiotics in the Prevention and Treatment of Atherosclerosis

Victoria L O'Morain  1 , Dipak P Ramji  1
Affiliations
Review

The Potential of Probiotics in the Prevention and Treatment of Atherosclerosis

Victoria L O'Morain et al. Mol Nutr Food Res. 2020 Feb.

Abstract

Atherosclerosis, the underlying cause of cardiovascular diseases such as myocardial infarction, cerebrovascular accident, and peripheral vascular disease, is the leading cause of global mortality. Current therapies against atherosclerosis, which mostly target the dyslipidemia associated with the disease, have considerable residual risk for cardiovascular disease together with various side effects. In addition, the outcomes from clinical trials on many promising pharmaceutical agents against atherosclerosis (e.g., low-dose methotrexate, inhibitors against cholesteryl ester transfer protein) have been disappointing. Nutraceuticals such as probiotic bacteria have, therefore, generated substantial recent interest for the prevention of atherosclerosis and potentially as add-ons with current pharmaceutical drugs. This review will discuss the current understanding of the anti-atherogenic actions of probiotics from preclinical and clinical studies together with their potential underlying mechanisms of action.

Keywords: atherosclerosis; cardiovascular disease; dyslipidemia; inflammation; nutraceuticals; probiotics.

PubMed Disclaimer

References

    1. J. W. E. Moss, D. P. Ramji, Nat. Rev. Cardiol. 2016, 13, 513.
    1. J. W. E. Moss, J. O. Williams, D. P. Ramji, Biochim. Biophy. Acta 2018, 1864, 1562.
    1. J. E. McLaren, D. R. Michael, T. G. Ashlin, D. P. Ramji, Prog. Lipid Res. 2011, 331.
    1. D. P. Ramji, T. S. Davies, Cytokine Growth Factor Rev. 2015, 26, 673.
    1. B. A. Ference, H. N. Ginsberg, I. Graham, K. K. Ray, C. J. Packard, E. Bruckert, R. A. Hegele, R. M. Krauss, F. J. Raal, H. Schunkert, G. F. Watts, J. Borén, S. Fazio, J. D. Horton, L. Masana, S. J. Nicholls, B. G. Nordestgaard, B. van de Sluis, M. R. Taskinen, L. Tokgözoglu, U. Landmesser, U. Laufs, O. Wiklund, J. K. Stock, M. J. Chapman, A. L. Catapano, Eur. Heart J. 2017, 38, 2459.

Publication types

LinkOut - more resources